343 related articles for article (PubMed ID: 31303976)
1. Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease.
Dai L; Qureshi AR; Witasp A; Lindholm B; Stenvinkel P
Comput Struct Biotechnol J; 2019; 17():721-729. PubMed ID: 31303976
[TBL] [Abstract][Full Text] [Related]
2. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage.
Dai L; Schurgers LJ; Shiels PG; Stenvinkel P
Nephrol Dial Transplant; 2020 Mar; 35(Suppl 2):ii31-ii37. PubMed ID: 32162665
[TBL] [Abstract][Full Text] [Related]
3. Ageing, cellular senescence and chronic kidney disease: experimental evidence.
Tan H; Xu J; Liu Y
Curr Opin Nephrol Hypertens; 2022 May; 31(3):235-243. PubMed ID: 35142744
[TBL] [Abstract][Full Text] [Related]
4. Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease-A Novel Target for Treatment.
Hobson S; Arefin S; Kublickiene K; Shiels PG; Stenvinkel P
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717151
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.
Wang WJ; Cai GY; Chen XM
Oncotarget; 2017 Sep; 8(38):64520-64533. PubMed ID: 28969091
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
7. Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies.
Wang Y; Wang Y; Yang M; Ma X
Biomed Pharmacother; 2021 Mar; 135():111191. PubMed ID: 33418306
[TBL] [Abstract][Full Text] [Related]
8. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
Xu J; Zhou L; Liu Y
Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
[TBL] [Abstract][Full Text] [Related]
9. Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification.
Hénaut L; Sanchez-Nino MD; Aldamiz-Echevarría Castillo G; Sanz AB; Ortiz A
Expert Opin Ther Targets; 2016; 20(1):89-105. PubMed ID: 26788590
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 in early vascular ageing: Calcification, senescence and therapy.
Arefin S; Buchanan S; Hobson S; Steinmetz J; Alsalhi S; Shiels PG; Kublickiene K; Stenvinkel P
Clin Chim Acta; 2020 Jun; 505():108-118. PubMed ID: 32097628
[TBL] [Abstract][Full Text] [Related]
11.
Stenvinkel P; Luttropp K; McGuinness D; Witasp A; Qureshi AR; Wernerson A; Nordfors L; Schalling M; Ripsweden J; Wennberg L; Söderberg M; Bárány P; Olauson H; Shiels PG
Aging (Albany NY); 2017 Feb; 9(2):494-507. PubMed ID: 28192277
[TBL] [Abstract][Full Text] [Related]
12. The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential.
Nath KA; O'Brien DR; Croatt AJ; Grande JP; Ackerman AW; Nath MC; Yamada S; Terzic A; Tchkonia T; Kirkland JL; Katusic ZS
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1493-F1499. PubMed ID: 30019935
[TBL] [Abstract][Full Text] [Related]
13. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies.
Toutfaire M; Bauwens E; Debacq-Chainiaux F
Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343
[TBL] [Abstract][Full Text] [Related]
14. Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis.
Yang Y; Mihajlovic M; Masereeuw R
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760849
[TBL] [Abstract][Full Text] [Related]
15. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
17. Heart Disease and Ageing: The Roles of Senescence, Mitochondria, and Telomerase in Cardiovascular Disease.
Booth LK; Redgrave RE; Tual-Chalot S; Spyridopoulos I; Phillips HM; Richardson GD
Subcell Biochem; 2023; 103():45-78. PubMed ID: 37120464
[TBL] [Abstract][Full Text] [Related]
18. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease.
Schroth J; Thiemermann C; Henson SM
Front Cell Dev Biol; 2020; 8():564461. PubMed ID: 33163486
[TBL] [Abstract][Full Text] [Related]
19. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
[TBL] [Abstract][Full Text] [Related]
20. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
Mathew S; Davies M; Lund R; Saab G; Hruska KA
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
